Larson, Peter et al. published their research in ACS Medicinal Chemistry Letters in 2017 |CAS: 5098-14-6

The Article related to imidazoquinoline preparation tlr7 tlr8 agonist structure activity relationship, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 5098-14-6

On November 9, 2017, Larson, Peter; Kucaba, Tamara A.; Xiong, Zhengming; Olin, Michael; Griffith, Thomas S.; Ferguson, David M. published an article.Application of 5098-14-6 The title of the article was Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8. And the article contained the following:

A series of N1-modified imidazoquinolines were synthesized and screened for Toll-like receptors (TLR) 7 and 8 activities to identify recognition elements that confer high affinity binding and selectivity. These receptors are key targets in the development of immunomodulatory agents that signal the NF-κB mediated transcription of pro-inflammatory chemokines and cytokines. Results are presented showing both TLR7/8 activations are highly correlated to N1-substitution, with TLR8 selectivity achieved through inclusion of an ethyl-, propyl-, or butylamino group at this position. While the structure-activity relationship anal. indicates TLR7 activity is less sensitive to N1-modification, extension of the aminoalkyl chain length to pentyl and p-methylbenzyl elicited high affinity TLR7 binding. Cytokine profiles are also reported that show the pure TLR8 agonist [4-amino-2-butyl-1-(2-aminoethyl)-7-methoxycarbonyl-1H-imidazo[4,5-c]quinoline] (I) induces higher levels of IL-1β, IL-12, and IFNγ when compared with TLR7 selective or mixed TLR7/8 agonists. The results are consistent with previous work suggesting TLR8 agonists are Th1 polarizing and may help promote cell-mediated immunity. The experimental process involved the reaction of 2-Aminomalononitrile 4-methylbenzenesulfonate(cas: 5098-14-6).Application of 5098-14-6

The Article related to imidazoquinoline preparation tlr7 tlr8 agonist structure activity relationship, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 5098-14-6

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Frank, I. et al. published their research in Synthetic Communications in 1990 |CAS: 5098-14-6

The Article related to aminocyanoheteroarylimidazole, imidazole aminocyanoheteroaryl, formimidate aminomalodinitrile cyclocondensation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Formula: C10H11N3O3S

On August 31, 1990, Frank, I.; Zeller, M. published an article.Formula: C10H11N3O3S The title of the article was 5-Amino-4-cyano-1-(hetero)arylimidazoles. And the article contained the following:

Title compounds I (R = 2-pyridyl, 3-pyridyl, 2-pyrimidinyl, 2-ClC6H4, 4-ClC6H4, 2,4-Cl2C6H3, 2,4-Me2C6H3, 5-chloro-2-pyridyl, 3,5-dichloro-2-pyridyl, 2-chloro-3-pyridyl) were prepared by the cyclocondensation of RN:CHOEt with NCCH(NH2)CN.p-MeC6H4SO3H. The experimental process involved the reaction of 2-Aminomalononitrile 4-methylbenzenesulfonate(cas: 5098-14-6).Formula: C10H11N3O3S

The Article related to aminocyanoheteroarylimidazole, imidazole aminocyanoheteroaryl, formimidate aminomalodinitrile cyclocondensation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Formula: C10H11N3O3S

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Shimojo, Masato et al. published their patent in 2003 |CAS: 34662-29-8

The Article related to imidazoarene preparation composition prostaglandin e2 ep4 antagonist, benzimidazole imidazopyridine preparation composition il6 disease, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Related Products of 34662-29-8

On October 23, 2003, Shimojo, Masato; Taniguchi, Kana published a patent.Related Products of 34662-29-8 The title of the patent was Preparation of imidazoarenes as prostaglandin E2 subtype EP4 receptor antagonists for treatment of IL-6 involved diseases. And the patent contained the following:

The present invention relates to the use of a prostaglandin E2 (PGE2) subtype EP4 receptor ligand in the manufacture of a medicament for the treatment of interleukin 6 (IL-6) involved diseases, such as alc. cirrhosis, amyloidosis, atherosclerosis, cardiac disease, sclerosis, and organ transplantation reactions (no data). The invention also relates to the assay which comprises culturing peripheral whole blood with a test compound and determining the effect of the compound on PGE2-induced whole blood cells activation. Three hundred eighty title compounds I [wherein Y1-Y4 = N, CH, CL; R1 = H, (un)substituted alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, pyrrolidinyl, amino, etc.; A = (un)substituted 5-6 membered (un)substituted monocyclic (hetero)aromatic ring; B = halo-substituted alkylene, cycloalkylene, alkenylene, alkynylene, alkyleneoxy, etc., optionally substituted with an oxo or alkyl group; W = amino, O, S, bond, etc.; R2 = H, OH, alkyl, alkoxy; Z = 5-12 membered (un)substituted monocyclic or bicyclic (hetero)aryl; L = halo, alkyl, haloalkyl, OH, alkoxy, haloalkoxy, alkylthio, NO2, amino, etc.] were prepared Thus, cycloaddition of 2-[4-[(3-amino-4,6-dimethyl-2-pyridinyl)amino]phenyl]ethanol (4-step preparation given) with propionyl chloride in toluene provided 2-[4-(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]ethyl propionate, which was treated with aqueous LiOH to give the ethanol derivative (86%). Chlorination (90%) using thionyl chloride, conversion to the azide (85%), and Pd/C catalyzed hydrogenation afforded the amine (94%). Coupling of the amine with p-toluenesulfonyl isocyanate in CH2Cl2 gave II (56%). The latter significantly inhibited IL-6 secretion by PGE2 in ConA-stimulated human peripheral blood mononuclear cells (PBMC). The experimental process involved the reaction of 3-Chloro-4-nitrobenzonitrile(cas: 34662-29-8).Related Products of 34662-29-8

The Article related to imidazoarene preparation composition prostaglandin e2 ep4 antagonist, benzimidazole imidazopyridine preparation composition il6 disease, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Related Products of 34662-29-8

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

McCauley, John A. et al. published their patent in 2001 |CAS: 337965-61-4

The Article related to benzimidazole preparation analgesic, benzyl benzimidazole preparation glutamate receptor antagonist, heteroaryl benzimidazole preparation nmda nr2b antagonist, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Formula: C7H5FN2

On May 10, 2001, McCauley, John A.; Theberge, Cory R.; Liverton, Nigel J.; Claremon, David A.; Claiborne, Christopher F. published a patent.Formula: C7H5FN2 The title of the patent was Preparation of 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists. And the patent contained the following:

Novel benzimidazoles, substituted in the 2-position by substituted benzyl groups or heteroaryl groups, (I) [wherein R1, R2, R4, and R5 = independently H, Cl, F, OH, OMe, CF3, OCF3, NH2, CN, NO2, (amino)alkyl, aryl, alkylcarbonylamino, oxohydroxydibenzopyranyl-substituted carboxyphenylthioureido or carbonylaminoalkylcarbonylamino, R6SO2NH, R6SO2NMe, or R6SO2NHCH2; R3 = H, OH, NH2, alkylamino, arylamino, or :O; R6 = (un)substituted alkyl, (phenyl)alkenyl, Ph, naphthyl, or heterocyclic group; Y = O, NH, (CH2)nCO(CH2)n, or (CH2)nCHR3(CH2)n; n = 0-5; Ar may be substituted with 0-3 N atoms in positions 2, 3, 5, or 6] were prepared as effective NMDA NR2B glutamate receptor antagonists. For example, cycloaddition of phenylenediamine and (4-phenoxyphenyl)acetic acid in presence of EDC and HOBt in DMF afforded 2-(4-phenoxybenzyl)-1H-benzimidazole. Exptl. protocols for assessing the inhibition of NR1A/2B NMDA receptor activation (FLIPR assay) and determining the apparent dissociation constants against the human NR1A/NR2B receptor (binding assay) are given (no data). I are useful for relieving pain and treating depression, schizophrenia, Parkinson’s disease, or stroke (no data). The experimental process involved the reaction of 2-(6-Fluoropyridin-3-yl)acetonitrile(cas: 337965-61-4).Formula: C7H5FN2

The Article related to benzimidazole preparation analgesic, benzyl benzimidazole preparation glutamate receptor antagonist, heteroaryl benzimidazole preparation nmda nr2b antagonist, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Formula: C7H5FN2

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Cai, Sui Xiong et al. published their patent in 2003 |CAS: 75629-62-8

The Article related to aryl pyrrolochromene analog preparation caspase activator apoptosis inducer, antitumor agent aryl pyrrolochromene analog preparation pharmaceutical composition, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Related Products of 75629-62-8

On November 27, 2003, Cai, Sui Xiong; Jiang, Songchun; Kemnitzer, William E.; Zhang, Hong; Attardo, Giorgio; Denis, Real published a patent.Related Products of 75629-62-8 The title of the patent was Preparation of substituted 4-aryl-4H-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and their uses against cancer and other disorders. And the patent contained the following:

The present invention is directed to substituted 4-aryl-4H-pyrrolo[2,3-h]chromenes and analogs thereof (shown as I; variables defined below; e.g. II). The present invention also relates to the discovery that compounds I are activators of caspases and inducers of apoptosis. Therefore, I can be used to induce cell death in a variety of clin. conditions in which uncontrolled growth and spread of abnormal cells occurs. The ability to activate the caspase cascade and induce apoptosis in human breast cancer cell lines T-47D and ZR-75-1 was measured for ∼50 examples of I, e.g. EC50 (nM) = 2.3 and 1.6, resp., for II. Although the methods of preparation are not claimed, ∼50 example preparations are included. For I: R1 = alkyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, haloalkyl, alkoxyalkyl, aminoalkyl and oxiranylalkyl; R3 and R4 = H, halo, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, C1-10 alkyl, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, nitro, amino, cyano, acylamido, hydroxy, thiol, acyloxy, azido, alkoxy, carboxy, methylenedioxy, carbonylamido or alkylthio; R5 is H or C1-10 alkyl. A is (un)substituted and is aryl, heteroaryl, saturated carbocyclic, partially saturated carbocyclic, saturated heterocyclic, partially saturated heterocyclic or arylalkyl; D is (un)substituted and is a heteroaromatic, partially saturated (un)saturated heterocyclic fused ring, wherein said fused ring has 5 or 6 ring atoms, wherein one or two of said ring atoms are N atoms and the others of said ring atoms are C atoms. Y is CN, COR19, CO2R19 or CONR20R21, wherein R19, R20 and R21 = H, C1-10-alkyl, haloalkyl, aryl, fused aryl, carbocyclic, a heterocyclic group, a heteroaryl group, alkenyl, alkynyl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, carbocycloalkyl, heterocycloalkyl, hydroxyalkyl or aminoalkyl; or R20 and R21 are taken together with the N to form a heterocycle; and Z is NR22R23, NHCOR22N(COR23)2, N(COR22)(COR23), N:CHOR19 or N:CHR19 wherein R22 and R23 = H, C1-4 alkyl or aryl, or R22 and R23 are combined together with the group attached to them to form a heterocycle. The experimental process involved the reaction of 2-((1H-Indol-3-yl)methylene)malononitrile(cas: 75629-62-8).Related Products of 75629-62-8

The Article related to aryl pyrrolochromene analog preparation caspase activator apoptosis inducer, antitumor agent aryl pyrrolochromene analog preparation pharmaceutical composition, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Related Products of 75629-62-8

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Goeker, Hakan et al. published their research in Journal of Heterocyclic Chemistry in 2009 |CAS: 34662-29-8

The Article related to benzimidazole preparation nucleophilic substitution reduction aryl diamine benzaldehyde heterocyclization, fungal infection antifungal structure activity candida, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 34662-29-8

On September 30, 2009, Goeker, Hakan; Alp, Mehmet; Ates-Alagoez, Zeynep; Yildiz, Sulhiye published an article.Application of 34662-29-8 The title of the article was Synthesis and potent antifungal activity against Candida species of some novel 1H-benzimidazoles. And the article contained the following:

A series of 47 novel N1-alkylated-2-aryl-5(6)-substituted-1H-benzimidazoles and their three novel indole analogs were synthesized and evaluated for in vitro antifungal activities against Candida species by the tube dilution method. The results showed that I and II, having pyridine at the position C-2, of benzimidazoles exhibited the greatest activity with MIC values of 6.25-3.12 μg/mL. Indole analogs III (R1 = H, R2 = Br; R1 = Pr, R2 = Br, CN) have no inhibitory activity. The experimental process involved the reaction of 3-Chloro-4-nitrobenzonitrile(cas: 34662-29-8).Application of 34662-29-8

The Article related to benzimidazole preparation nucleophilic substitution reduction aryl diamine benzaldehyde heterocyclization, fungal infection antifungal structure activity candida, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 34662-29-8

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Sedighian, Hadi et al. published their research in Phosphorus, Sulfur and Silicon and the Related Elements in 2022 |CAS: 2510-01-2

The Article related to vinylmalononitrile potassium selenocyanate benzoyl chloride tandem heterocyclization, benzoylimino fused selenopyran preparation ultrasonication, Heterocyclic Compounds (One Hetero Atom): Other 6-Membered Rings and other aspects.Recommanded Product: 2510-01-2

Sedighian, Hadi; Imani, Kaveh; Bazgir, Ayoob published an article in 2022, the title of the article was Ultrasound-assisted a domino three-component reaction to polycyclic selenopyrans synthesis.Recommanded Product: 2510-01-2 And the article contains the following content:

A novel and efficient three-component reaction of substituted benzoyl chlorides, potassium selenocyanate and vinyl malononitriles was developed for the synthesis of polycyclic selenopyrans via an ultrasound-assisted domino vinylogous nucleophilic reaction/intramol. selenocyclization/imine-enamine tautomerization reaction. Introducing a simple one-step method and use of available starting materials and mild reaction conditions are the most important advantages of this strategy. The experimental process involved the reaction of 2-(2,3-Dihydro-1H-inden-1-ylidene)malononitrile(cas: 2510-01-2).Recommanded Product: 2510-01-2

The Article related to vinylmalononitrile potassium selenocyanate benzoyl chloride tandem heterocyclization, benzoylimino fused selenopyran preparation ultrasonication, Heterocyclic Compounds (One Hetero Atom): Other 6-Membered Rings and other aspects.Recommanded Product: 2510-01-2

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Lee, Jennifer et al. published their patent in 2018 |CAS: 882978-62-3

The Article related to hdac11 inhibitor cell proliferative disorder treatment, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Synthetic Route of 882978-62-3

On April 26, 2018, Lee, Jennifer; Burnette, Pearlie; Chellappan, Srikumar; Barczak, Nicholas; Conti, Chiara; Escobedo, Jaime A.; Han, Bingsong; Lancia, David R., Jr.; Liu, Cuixian; Martin, Matthew W.; Ng, Pui Yee; Rudnitskaya, Aleksandra; Thomason, Jennifer R.; Zheng, Xiaozhang published a patent.Synthetic Route of 882978-62-3 The title of the patent was Methods using histone deacetylase 11 (HDAC11) inhibitors for treating proliferative diseases. And the patent contained the following:

The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for example, cell proliferative diseases. The experimental process involved the reaction of 4,5-Diamino-2-(trifluoromethyl)benzonitrile(cas: 882978-62-3).Synthetic Route of 882978-62-3

The Article related to hdac11 inhibitor cell proliferative disorder treatment, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Synthetic Route of 882978-62-3

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Stairs, Shaun et al. published their research in Nature Communications in 2017 |CAS: 5098-14-6

The Article related to oxazoline pyrimidine 8 oxo purine ribonucleotide, Carbohydrates: Nucleosides and Nucleotides, Cobalamins, Riboflavin and other aspects.Quality Control of 2-Aminomalononitrile 4-methylbenzenesulfonate

On January 3, 2017, Stairs, Shaun; Nikmal, Arif; Bucar, Dejan-Kresimir; Zheng, Shao-Liang; Szostak, Jack W.; Powner, Matthew W. published an article.Quality Control of 2-Aminomalononitrile 4-methylbenzenesulfonate The title of the article was Divergent prebiotic synthesis of pyrimidine and 8-oxo-purine ribonucleotides. And the article contained the following:

Understanding prebiotic nucleotide synthesis is a long standing challenge thought to be essential to elucidating the origins of life on Earth. Recently, remarkable progress has been made, but to date all proposed syntheses account sep. for the pyrimidine and purine ribonucleotides; no divergent synthesis from common precursors has been proposed. Moreover, the prebiotic syntheses of pyrimidine and purine nucleotides that have been demonstrated operate under mutually incompatible conditions. Here, we tackle this mutual incompatibility by recognizing that the 8-oxo-purines share an underlying generational parity with the pyrimidine nucleotides. We present a divergent synthesis of pyrimidine and 8-oxo-purine nucleotides starting from a common prebiotic precursor that yields the β-ribo-stereochem. found in the sugar phosphate backbone of biol. nucleic acids. The generational relationship between pyrimidine and 8-oxo-purine nucleotides suggests that 8-oxo-purine ribonucleotides may have played a key role in primordial nucleic acids prior to the emergence of the canonical nucleotides of biol. The experimental process involved the reaction of 2-Aminomalononitrile 4-methylbenzenesulfonate(cas: 5098-14-6).Quality Control of 2-Aminomalononitrile 4-methylbenzenesulfonate

The Article related to oxazoline pyrimidine 8 oxo purine ribonucleotide, Carbohydrates: Nucleosides and Nucleotides, Cobalamins, Riboflavin and other aspects.Quality Control of 2-Aminomalononitrile 4-methylbenzenesulfonate

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Cao, Dongdong et al. published their research in Asian Journal of Organic Chemistry in 2020 |CAS: 2510-01-2

The Article related to nitrobenzofuran alkylidene malononitrile cyclization, dibenzofuran preparation, Heterocyclic Compounds (One Hetero Atom): Areno- and Diarenofurans and other aspects.Synthetic Route of 2510-01-2

On October 31, 2020, Cao, Dongdong; Chen, Dingben; Chen, Gang; Mo, Hanjie; Xia, Zhijun; Li, Kai-bin; Yang, Jianguo published an article.Synthetic Route of 2510-01-2 The title of the article was Synthesis of Dibenzofurans Derivatives via Benzannulation of 2-Nitrobenzofurans and Alkylidene Malononitriles. And the article contained the following:

Although various methods for the preparation of dibenzofurans are available, an efficient, general synthesis of dibenzofurans from benzofurans remains an unsolved problem. Herein, we provide the first benzannulation of readily prepared 2-nitrobenzofurans with alkylidene malononitriles. This methodol. enables facile assembly of a wide variety of highly functionalized dibenzofurans in moderate to excellent yields under metal-free conditions. Gram-scale synthesis and further elaborations of the product were succesfully performed, demonstrating synthetic utility of this method. The experimental process involved the reaction of 2-(2,3-Dihydro-1H-inden-1-ylidene)malononitrile(cas: 2510-01-2).Synthetic Route of 2510-01-2

The Article related to nitrobenzofuran alkylidene malononitrile cyclization, dibenzofuran preparation, Heterocyclic Compounds (One Hetero Atom): Areno- and Diarenofurans and other aspects.Synthetic Route of 2510-01-2

Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts